Login / Signup

OPRM1 Moderates Daily Associations of Naltrexone Adherence With Alcohol Consumption: Preliminary Evidence From a Mobile Health Trial.

Christian S HendershotSarah S DermodyJeffrey D WardellMichelle J ZasoJames L KennedySusan A Stoner
Published in: Alcoholism, clinical and experimental research (2020)
These findings suggest that high-density assessments and person-centered analytic approaches, including modeling within-person variation in medication adherence, could be advantageous for pharmacogenetic studies.
Keyphrases
  • high density
  • alcohol consumption
  • study protocol
  • clinical trial
  • phase iii
  • physical activity
  • phase ii
  • case control
  • randomized controlled trial
  • alcohol use disorder
  • weight loss
  • insulin resistance